Over the summer, 23andMe launched a collaborative study with Pfizer to study and research inflammatory bowel disease (IBD).
“We’ve been encouraged by the number of people diagnosed with either Crohn’s disease or ulcerative colitis who have joined the study.”
Read full article about the collaborative study here: http://bit.ly/1TA1FF9
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?